EDESA BIOTECH EDSA 深 沪
已收盘 09-19 16:00:00 美东时间
2.47
+0.170
+7.39%
华盛通- 最 高2.47
- 今 开2.3101
- 成交量 2.89万股
- 最 低 2.3101
- 昨 收 2.30
- 总市值 1734.61万
- 52周最高 5.00
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.55
- 委 比 -93.32%
- 总股本 702.27万
- 历史最高 133.70
- 量 比 5.16
- 振 幅 6.95%
- 历史最低 1.55
- 每 手 1
- 风险率 0.55%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Edesa Biotech Launches At-The-Market Offering Program
An announcement from Edesa Biotech ( ($EDSA) ) is now available. On September 9...
09-10 05:00
氪星晚报 ｜霸王茶姬正式进入菲律宾市场；宇树科技宣布将在四季度提交IPO申请；金价迭创新高，多家黄金企业半年净利润翻倍
大公司： “应帆科技”完成亿元A轮融资 36氪获悉，9月1日，“应帆科技”宣布完成亿元级战略A轮融资。此轮投资人涵盖政府产业引导基金、多元产业投资机构，以及科技...
09-02 21:04
三店同开，霸王茶姬正式进入菲律宾市场
日前，霸王茶姬在菲律宾的三家门店同时开业，首次进入菲律宾市场。据了解，这三家门店分别位于SM North EDSA、Robinsons Galleria和...
09-02 16:20
霸王茶姬联手蓝海资本，追加投资加速全球化布局
（来源：辰珵） 三店齐开，文化出海提速，中国新茶饮迈向全球化新阶段 【2025年8月，马尼拉讯】—— 继凤凰网报道的霸王茶姬与蓝海资本战略合作后，双方再次释放...
08-24 06:16
Edesa Biotech Advances Vitiligo Treatment Amidst Steady Financial Performance
Edesa Biotech ( ($EDSA) ) has provided an announcement. Edesa Biotech reported ...
08-09 07:02
Edesa Biotech Q3 EPS $(0.25) Beats $(0.29) Estimate
Edesa Biotech (NASDAQ:EDSA) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.29) by 13.79 percent. This is a 51.92 percent increase over losses of $(0.52) per share from the
08-09 04:36
Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results
Edesa Biotech reported Q3 and Q9 2025 financial results, advancing manufacturing for its EB06 candidate in vitiligo with plans to submit IND data by end-2025. CEO Par Nijhawan highlighted EB06's favorable safety profile and potential benefits for patients with extensive vitiligo. Financially, operating expenses remained stable, with a slight decrease in R&D costs offset by increased EB06-related expenses. Net loss for Q3 and Q9 2025 was $1.7M and...
08-08 20:35
美股大行评级 | 潜在涨幅205.56%！康托·菲茨杰拉德上调HIVE Digital Technologies目标价至5.5美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1145638202455883776.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 康托·菲茨杰拉德：维持HIVE Digital Technologies(HIVE)"超配"评级，目标价从5美元升至5.5美元</p> <p>• BTIG：维持Theravance Biopharma(TBPH)"买入"评
06-28 08:37
HC Wainwright & Co. Assumes Edesa Biotech at Buy, Announces Price Target of $5
HC Wainwright & Co. analyst Yi Chen assumes Edesa Biotech (NASDAQ:EDSA) with a Buy rating and announces Price Target of $5.
06-27 23:24
